Skip to content
by Legal Desire
17 November 2026

Sidley Represents RemeGen in Expanded US$356 Million Licensing Agreement With Vor Bio

Advising firms

Deal team

5 lawyers named
LawyerFirmSeniorityPracticeOffice
Lila Hope Lead Sidley Not stated Technology and Life Sciences Transactions Not stated
Jiqiang (JQ) Lin Lead Sidley Not stated Technology and Life Sciences Transactions Not stated
Joanna Wu Sidley Not stated Technology and Life Sciences Transactions Not stated
Yuhan Wu Sidley Not stated Technology and Life Sciences Transactions Not stated
Steven M. Przesmicki Sidley Not stated Emerging Companies and Venture Capital Not stated

2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 356m (US$356 Million)
What the figure measures
Total transaction value
Client
RemeGen Co., Ltd.Sell-side
Counterparties
Vor Bio (Buy-side)